Evaluation of The Cycle SyncingⓇ Method: A 12-Week Virtual Clinical Trial

Evaluation of The Cycle SyncingⓇ Method: A 12-Week Virtual Clinical Trial

This 12-week, 100% virtual single-group open-label trial evaluates the Cycle SyncingⓇ Method using the MyFLO app, MIRA hormonal monitoring, and continuous glucose monitoring to assess reduction in menstrual cycle symptom burden and hormonal regulation.

Inclusion Criteria:

• Female participants aged 22 - 42 years
• Regular menstrual cycles
• Willingness and ability to comply with daily app usage and device protocols
• Access to a compatible smartphone and reliable internet connection
• Ability to attend a weekly virtual call with study personnel

Exclusion Criteria:

• Current pregnancy or breastfeeding
• Use of hormonal contraceptives or other medications known to alter menstrual cycle physiology
• Presence of significant comorbidities or chronic conditions that may interfere with study participation
• Any condition that, in the investigator's opinion, would make participation unsafe